PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
4.56%
Revenue growth of 4.56% vs. zero growth in Healthcare. Walter Schloss might still want to see if it can translate into profits.
2.69%
Gross profit growth of 2.69% while Healthcare median is zero. Walter Schloss might see a slight advantage that could be built upon.
5.94%
EBIT growth of 5.94% while Healthcare median is zero. Walter Schloss would see a marginal edge that could be expanded upon.
0.67%
Positive operating income growth while Healthcare is negative. Peter Lynch would spot a big relative advantage here.
-4.69%
Negative net income growth while Healthcare median is 0.00%. Seth Klarman would investigate factors dragging net income down.
-4.70%
Negative EPS growth while Healthcare median is 0.00%. Seth Klarman would explore whether share dilution or profit declines are to blame.
-4.70%
Negative diluted EPS growth while Healthcare median is 0.00%. Seth Klarman would look for the cause: weakened profitability or heavier share issuance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Dividend cuts while Healthcare median is 0.00%. Seth Klarman would see if others maintain or grow payouts, highlighting a relative weakness.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
7.03%
10Y CAGR of 7.03% while Healthcare median is zero. Walter Schloss might see a slight advantage that can compound over very long horizons.
-7.20%
Negative 5Y CAGR while Healthcare median is 0.00%. Seth Klarman would see if others are at least growing moderately, indicating a firm-specific problem.
-32.91%
Negative 3Y CAGR while Healthcare median is 0.00%. Seth Klarman would examine if the sector is otherwise stable, indicating a company-specific issue.
-100.00%
Negative 10Y OCF/share CAGR while Healthcare median is 0.00%. Seth Klarman would suspect the firm is failing to keep pace with industry peers.
-100.00%
Negative 5Y OCF/share CAGR while Healthcare median is 0.00%. Seth Klarman might see a firm-specific issue if peers still expand cash flow.
No Data
No Data available this quarter, please select a different quarter.
24.45%
Net income/share CAGR 1.25-1.5x Healthcare median. Mohnish Pabrai would confirm that management’s capital allocation strategy drives the outperformance.
15.10%
5Y net income/share CAGR 1.25-1.5x Healthcare median. Mohnish Pabrai would check that top-line growth and share count management both contribute.
-43.23%
Negative 3Y CAGR while Healthcare median is 5.07%. Seth Klarman might see a pressing concern if the rest of the sector is stable or growing.
No Data
No Data available this quarter, please select a different quarter.
33.35%
5Y equity/share CAGR of 33.35% while Healthcare median is zero. Walter Schloss sees a slight positive that might compound if management executes well.
-12.89%
Negative 3Y equity/share growth while Healthcare median is 5.19%. Seth Klarman sees a short-term weakness if peers still expand net worth.
-100.00%
Dividend declines over 10 years while Healthcare median is 0.00%. Seth Klarman would see a relative disadvantage if peers consistently raised payouts.
-100.00%
Dividend cuts or stagnation while Healthcare median is 0.00%. Seth Klarman sees a disadvantage in shareholder returns vs. peers.
No Data
No Data available this quarter, please select a different quarter.
-99.40%
AR shrinking while Healthcare median grows. Seth Klarman sees potential advantage unless it signals declining demand.
0.08%
Inventory growth of 0.08% while Healthcare median is zero. Walter Schloss checks if we’re preparing for a sales push or risking overstock.
1.93%
Asset growth of 1.93% while Healthcare median is zero. Walter Schloss sees a slight advantage if expansions yield good returns on capital.
4.20%
BV/share growth of 4.20% while Healthcare is zero. Walter Schloss sees a slight lead that can expand if sustained over time.
-34.68%
Debt is shrinking while Healthcare median is rising. Seth Klarman might see an advantage if growth remains possible.
No Data
No Data available this quarter, please select a different quarter.
82.29%
SG&A growth of 82.29% while Healthcare median is zero. Walter Schloss sees a modest overhead increase needing revenue justification.